Metabolism of 5-Fluorouracil into Fluoroacetate in Rats
Author Information
Author(s): M Arellano, M Malet-Martino, R Martino, P Gires
Primary Institution: Universit6 Paul Sabatier
Hypothesis
The study investigates the biotransformation of the anti-cancer drug 5-fluorouracil into toxic metabolites in rats.
Conclusion
The study demonstrates that 5-fluorouracil is metabolized into fluoroacetate and a-fluoro-β-hydroxypropionic acid, which may contribute to its cardiotoxic effects.
Supporting Evidence
- 5-fluorouracil was metabolized into fluoroacetate and a-fluoro-β-hydroxypropionic acid.
- Low amounts of these metabolites were detected in urine and perfusates.
- The cardiotoxicity of 5-fluorouracil may arise from its metabolism into these toxic compounds.
Takeaway
Researchers found that a cancer drug called 5-fluorouracil turns into harmful substances in rats, which could make the heart sick.
Methodology
The study used isolated perfused rat liver and in vivo rat models to analyze the metabolism of 5-fluorouracil using fluorine-19 NMR.
Limitations
The study's findings may not fully translate to humans due to differences in metabolism between species.
Participant Demographics
Male Wistar rats weighing 370-460 g were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website